Research Summary
Dr. Hobbs' research focuses on dosimetry, which measures and calculates the radiation dose received by matter and tissue that has been exposed to radiation.
His current studies examine various radiobiologic modeling techniques for treatment of specific tumors and cancers. Dr. Hobbs is also developing an alpha-particle dosimetry model that can examines alpha particles which are hard to study with current imaging modalities.
As part of his medical physics residency, Dr. Hobbs is studying the use and effectiveness of external beam radiation.
Selected Publications
RF Hobbs, H Song, CJ Watchmann, WE Bolch, AK Aksnes, T Ramdahl, GD Flux, George Sgouros.“A bone marrow toxicity model for ²²³Ra alpha-emitter radiopharmaceutical therapy”.Phys Med Biol 2012, 57(10):3207-22.
RF Hobbs, H Song, DL Huso, MHSundel, G Sgouros.“A nephron-based model of the kidneys for macro-to-microa-particle dosimetry”.Phys Med Biol 2012, 57(13):4403-24.
RF Hobbs, T McNutt, S Baechler, B He, CE Esaias, EC Frey, DM Loeb, RL Wahl, O Shokek, G Sgouros.“A treatment planning methodology for sequentially combining radiopharmaceutical therapy and external radiation therapy.”Int J Radiat Oncol Biol Phys 2011,80(4):1256-62.
RF Hobbs, S Baechler, S Senthamizhchelvan, AR Prideaux, CE Esaias, M Reinhardt, EC Frey, DM Loeb, G Sgouros. “A gamma camera count rate saturation correction method for whole body planar imaging”. Phys Med Biol 2010, 55(3):817-831.
RF Hobbs, S Baechler, DX Fu, CE Esaias, MG Pomper, RF Ambinder, G Sgouros. “A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy”. Med Phys 2011, 38(6):2892-2903.
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.